DK1294710T3 - Indolderivater, der er egnede til behandlingen af CNS-lidelser - Google Patents
Indolderivater, der er egnede til behandlingen af CNS-lidelserInfo
- Publication number
- DK1294710T3 DK1294710T3 DK01940240T DK01940240T DK1294710T3 DK 1294710 T3 DK1294710 T3 DK 1294710T3 DK 01940240 T DK01940240 T DK 01940240T DK 01940240 T DK01940240 T DK 01940240T DK 1294710 T3 DK1294710 T3 DK 1294710T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- cns disorders
- indole derivatives
- derivatives suitable
- indole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biophysics (AREA)
- Psychiatry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200000919 | 2000-06-14 | ||
US21244500P | 2000-06-16 | 2000-06-16 | |
PCT/DK2001/000406 WO2001096328A1 (fr) | 2000-06-14 | 2001-06-13 | Derives indoliques utilises dans le traitement de troubles du systeme nerveux central (snc) |
EP01940240A EP1294710B1 (fr) | 2000-06-14 | 2001-06-13 | Derives indoliques utilises dans le traitement de troubles du systeme nerveux central (snc) |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1294710T3 true DK1294710T3 (da) | 2005-10-03 |
Family
ID=32912594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01940240T DK1294710T3 (da) | 2000-06-14 | 2001-06-13 | Indolderivater, der er egnede til behandlingen af CNS-lidelser |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1468996B1 (fr) |
DK (1) | DK1294710T3 (fr) |
SI (1) | SI1294710T1 (fr) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA9711376B (en) * | 1996-12-20 | 1998-07-21 | Lundbeck & Co As H | Indole or dihydroindole derivatives |
GB9718833D0 (en) * | 1997-09-04 | 1997-11-12 | Merck Sharp & Dohme | Therapeutic agents |
GB9810886D0 (en) * | 1998-05-13 | 1998-07-22 | Lilly Industries Ltd | Pharmaceutical compounds |
GB9825413D0 (en) * | 1998-11-19 | 1999-01-13 | Lilly Co Eli | Pharmaceutical compounds |
KR20010085555A (ko) * | 1999-06-24 | 2001-09-07 | 히라이 가쯔히꼬 | 아드레날린 알파1비 수용체 길항약 |
GB2362381A (en) * | 2000-05-18 | 2001-11-21 | Lilly Co Eli | Pharmaceutically active indolyl-piperidines |
AR028685A1 (es) * | 2000-06-14 | 2003-05-21 | Lundbeck & Co As H | Derivados de indol |
-
2001
- 2001-06-13 EP EP04012325A patent/EP1468996B1/fr not_active Expired - Lifetime
- 2001-06-13 DK DK01940240T patent/DK1294710T3/da active
- 2001-06-13 SI SI200130395T patent/SI1294710T1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SI1294710T1 (en) | 2005-10-31 |
EP1468996A1 (fr) | 2004-10-20 |
EP1468996B1 (fr) | 2007-09-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1343773T3 (da) | Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser | |
DK1156813T3 (da) | Reovirus til behandling af cellulære proliferative lidelser | |
DK1474416T3 (da) | Dihydrobenzodiazepin-2-on-derivater til behandlingen af neurologiske lidelser | |
DK1656346T3 (da) | 1,2,3,4-tetrasubstituerede indol til behandling af luftvejssygdomme | |
DK1147083T3 (da) | Arylpiperazinyl-cyclohexylindolderivater til behandling af depression | |
DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
DK1063990T3 (da) | Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser | |
DK1165510T3 (da) | 1-arensulfonyl-2-aryl-pyrrolidin- og -piperidinderivater til behandling af CNS-lidelser | |
DK1392318T3 (da) | 15-keto-prostaglandiner til behandling af lægemiddelinduceret forstoppelse | |
DK2189162T3 (da) | Fremgangsmåder til behandling af cellulære proliferative forstyrrelser | |
DK1344526T3 (da) | Midler til forebyggelse/behandling af inflammatoriske luftvejslidelser | |
DK1468996T3 (da) | Indolderivater til behandling af CNS-sygdomme | |
DK1121356T3 (da) | 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser | |
NO20030127D0 (no) | Indolderivater nyttige for behandling av CNS-forstyrrelser | |
DK1268482T3 (da) | Pyranoindoler til behandling af glaukom | |
NO20026029L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
DK1468686T3 (da) | S-methyl-dihydro-ziprasidon til behandling af psykiatriske lidelser | |
DK1200447T3 (da) | Oxazinocarbazoler til behandling af CNS-sygdomme | |
DK1373232T3 (da) | Fremgangsmåde til fremstilling af N-substituerede 2,6-dialkylmorpholiner | |
DK1294694T3 (da) | Fremgangsmåde til fremstilling af quinolinderivater | |
DK1294710T3 (da) | Indolderivater, der er egnede til behandlingen af CNS-lidelser | |
NO20026028L (no) | Indolderivater nyttige for behandlingen av CNS-forstyrrelser | |
TR199902015A3 (tr) | Aril-sikloheksilamin türevlerinin CNS bozukluklarina karsi kullanilmasi. | |
DK1451177T3 (da) | Substituerede 2-pyrrolidin-2-yl-1H-indol-derivater til behandling af migræne |